CONSULTING AND SEPARATION AGREEMENTConsulting and Separation Agreement • September 16th, 2022 • SpringWorks Therapeutics, Inc. • Biological products, (no disgnostic substances) • Connecticut
This CONSULTING AND SEPARATION AGREEMENT (the “Agreement”) is entered into by and among Michael Burgess (“Dr. Burgess”), and SpringWorks Therapeutics, Inc., a Delaware corporation (the “Company”). This Agreement is entered into effective as of September 12, 2022. Dr. Burgess and the Company are hereinafter collectively referred to as the “Parties” and each are individually referred to as a “Party”.
